Erector Spinae Block in Reducing Peri-operative Opioid Consumption in Total Abdominal Hystrectomy

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age16-80
SponsorKulsoom International Hospital

About this trial

Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period. This can be reduced by using nerve blocks such as Erector spinae plane block.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

American Society of Anesthesiologists (ASA) class: I, II and III .

Elective Hysterectomy under General Anesthesia.

Disqualifiers

Lack of consent

Body mass index >35 kg/m2

Allergic to study medicine

Opioid abuse or misuse disorder

Trial design

Design model

Parallel

Treatments tested in this trial

  • Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)

    Drug

    Bilateral Erector Spinae Block at T10 level using 30ml of 0.25% Bupivacaine will be administered under Ultrasound guidance before surgical incision.

  • Placebo

    Drug

    Bilateral Erector Spinae Block at T10 level using 30ml of Normal saline will be administered under Ultrasound guidance before surgical incision.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Erector spinae groupActive comparator 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Total Intra-operative Fentanyl consumption

Time frame
From surgical incision till end of surgery

Secondary outcomes

1

Total amount of IV Tramadol consumed in post operative period

Time frame
First 24 hours after surgery
2

Post operative pain score

This will be assessed Visual Analog Scale

Time frame
Baseline that is pain score upon arrival in post anesthesia care unit in the post operative period and then at 1hours ,2 hours ,4 hours,6 hours,12 hours and 24 hours in the post operative period

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.